Tests of a single, cheap tablet combining a range of drugs that protect against heart disease and stroke have begun.
The “polypill” was mooted years ago as a cheap way to slash deaths from the big killer diseases, but pharmaceutical companies were reluctant to take on the project as the inexpensive drugs involved provided no financial incentive.
Now a team funded by the in London, UK, and the , and led by at the University of Auckland, New Zealand, has begun recruiting 700 volunteers in six countries for a pilot trial of a…
